ENDRA Life Sciences (NDRA) Non Operating Income (2017 - 2026)

ENDRA Life Sciences (NDRA) has reported Non Operating Income for 10 consecutive years, with $1.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non Operating Income rose 2085.75% year-over-year to $1.6 million in Q2 2026; TTM through Jun 2026 was $733076.0, a 487.44% increase from a year earlier, with the FY2025 full-year figure at -$1.3 million, down 83.02% from the prior year.
• Non Operating Income was $1.6 million for Q2 2026 at ENDRA Life Sciences, up from $862315.0 in the prior quarter.
• Over five years, Non Operating Income peaked at $1.6 million in Q2 2026 and troughed at -$1.5 million in Q4 2025.
• A 5-year average of $57912.8 and a median of $1700.0 in 2024 frame the typical range for Non Operating Income.
• The widest YoY moves for Non Operating Income: up 8513.15% in 2024, down 3093.96% in 2024.
• Over 5 years, Non Operating Income stood at $23785.0 in 2022, then tumbled by 107.38% to -$1756.0 in 2023, then surged by 8513.15% to $147735.0 in 2024, then plunged by 1147.27% to -$1.5 million in 2025, then surged by 206.21% to $1.6 million in 2026.
• The last three Non Operating Income figures came in at $1.6 million (Q2 2026), $862315.0 (Q1 2026), and -$1.5 million (Q4 2025), per Business Quant data.